Astellas Pharma Inc. (4503) : Company Profile and SWOT Analysis

  • July 2012
  • -
  • World Market Intelligence Ltd
  • -
  • 45 pages

Synopsis

World Market Intelligence's 'Astellas Pharma Inc. (4503) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, competitive benchmarking, key facts, key employees, location and subsidiaries as well as information on products and services.

Summary

This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.

WMI's 'Astellas Pharma Inc. (4503) : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.

WMI strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope

• Examines and identifies key information and issues about 'Astellas Pharma Inc.' for business intelligence requirements
• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
• Provides analysis on financial ratios along with a competitor benchmarking section
• The profile also contains information on business operations, company history, major products and services, key employees

Reasons To Buy

• Quickly enhance your understanding of the company
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
• Recognize potential partnerships and suppliers
• Obtain yearly profitability figures

Key Highlights

Astellas Pharma Inc. (Astellas) is a global pharmaceutical company focused on developing, manufacturing and marketing of pharmaceuticals and related products. The company has research and development capabilities to develop new drugs, manufacturing facilities for the manufacturing of products in a cost effective way and efficient in-house sales force to market those products. The company is active in the field of urology, transplantation and oncology. Key brands marketed by the company include Prograf, Vesicare, Protopic, Harnal and Funguard. Apart from Japan, Astellas supplies its products to global markets, including Ireland, the UK, Netherlands, China, Hong Kong, Thailand, Indonesia, and Philippines, among others. Astellas is headquartered at Chuo-Ku in Tokyo, Japan.

Table Of Contents

Table of Contents

1 Business Analysis
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Analysis of Key Performance Indicators
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
2.2.1 Revenue and Operating Profit
2.2.2 Asset and Liabilities
2.2.3 Operational Efficiency
2.2.4 Valuation
2.3 Competitive Benchmarking
2.3.1 Market Capitalization
2.3.2 Efficiency
2.3.3 Valuation
2.3.4 Turnover - Inventory and Asset
3 Mergers and Acquisitions and Partnerships
3.1 MandA and Partnerships Strategy
4 SWOT Analysis
4.1 SWOT Analysis - Overview
4.2 Strengths
4.3 Weaknesses
4.4 Opportunities
4.5 Threats
5 History
6 Key Employees
7 Key Employee Biographies
8 Locations and Subsidiaries
8.1 Head Office
8.2 Other Locations and Subsidiaries
9 Appendix
9.1 Methodology
9.2 Ratio Definitions
9.3 Disclaimer


List of Tables

Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: Key Capital Market Indicators
Table 5: History
Table 6: Key Employees
Table 7: Key Employee Biographies
Table 8: Subsidiaries
Table 9: Locations


List of Figures

Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Operational Efficiency
Figure 4: Valuation
Figure 5: Market Capitalization
Figure 6: Efficiency
Figure 7: Valuation
Figure 8: Turnover - Inventory and Asset

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Biogen Idec Inc. - Product Pipeline Review - 2014

Biogen Idec Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • April 2014
  • by Global Markets Direct

Biogen Idec Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Biogen Idec Inc. - Product Pipeline Review - 2014', provides an overview of the Biogen Idec Inc.'s pharmaceutical research ...

Drug and Medication Industry: Celgene Corporation – Product Pipeline Review – Q4 2010

Drug and Medication Industry: Celgene Corporation – Product Pipeline Review – Q4 2010

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...

Therametrics holding AG - Product Pipeline Review - 2014

Therametrics holding AG - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

Therametrics holding AG - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Therametrics holding AG - Product Pipeline Review - 2014', provides an overview of the Therametrics holding ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.